Laboratory of Cardiovascular Science, National Institute on Aging, National Institute of Health, Baltimore, Maryland, USA.
Laboratory of Cardiovascular Science, National Institute on Aging, National Institute of Health, Baltimore, Maryland, USA; Saitama International Medical Center, Saitama, Japan.
JACC Clin Electrophysiol. 2021 Nov;7(11):1331-1344. doi: 10.1016/j.jacep.2021.02.016. Epub 2021 Apr 28.
The purpose of this study was to discover regulatory universal mechanisms of normal automaticity in sinoatrial nodal (SAN) pacemaker cells that are self-similar across species.
Translation of knowledge of SAN automaticity gleaned from animal studies to human dysrhythmias (e.g., "sick sinus" syndrome [SSS]) requiring electronic pacemaker insertion has been suboptimal, largely because heart rate varies widely across species.
Subcellular Ca releases, whole cell action potential (AP)-induced Ca transients, and APs were recorded in isolated mouse, guinea pig, rabbit, and human SAN cells. Ca-Vm kinetic parameters during phases of AP cycles from their ignition to recovery were quantified.
Although both AP cycle lengths (APCLs) and Ca-Vm kinetic parameters during AP cycles differed across species by 10-fold, trans-species scaling of these during AP cycles and scaling of these to APCL in cells in vitro, electrocardiogram RR intervals in vivo, and body mass (BM) were self-similar (obeyed power laws) across species. Thus, APCL in vitro, heart rate in vivo, and BM of any species can be predicted by Ca-Vm kinetics during AP cycles in SAN cells measured in any single species in vitro.
In designing optimal heart rate to match widely different BM and energy requirements from mice to humans, nature did not "reinvent pacemaker cell wheels," but differentially scaled kinetics of gears that regulate the rates at which the "wheels spin." This discovery will facilitate the development of novel pharmacological and biological pacemakers featuring a normal, wide-range rate regulation in animal models and the translation of these to humans to target recalcitrant human SSS.
本研究旨在发现窦房结(SAN)起搏细胞正常自动性的调节普遍机制,这些机制在物种间具有自相似性。
从动物研究中获得的关于 SAN 自动性的知识转化为需要电子起搏器植入的人类心律失常(例如“病态窦房结”综合征[SSS])的效果并不理想,主要是因为心率在物种间差异很大。
在分离的小鼠、豚鼠、兔和人心房 SAN 细胞中记录亚细胞 Ca 释放、全细胞动作电位(AP)诱导的 Ca 瞬变和 AP。在 AP 周期从点火到恢复的各个阶段量化 Ca-Vm 动力学参数。
尽管 AP 周期长度(APCL)和 AP 周期中 Ca-Vm 动力学参数在物种间差异达 10 倍,但在 AP 周期和 AP 周期中这些参数的跨物种缩放以及这些参数与 APCL 的缩放在细胞内,在体内心电图 RR 间隔和体重(BM)在物种间是自相似的(遵循幂律)。因此,体外的 APCL、体内的心率和任何物种的 BM 都可以通过在任何单一物种的 SAN 细胞中测量的 AP 周期中的 Ca-Vm 动力学来预测。
在设计与从老鼠到人类的广泛不同的 BM 和能量需求相匹配的最佳心率时,大自然并没有“重新发明起搏器细胞轮”,而是对调节“轮子旋转速度”的齿轮动力学进行了差异缩放。这一发现将有助于开发具有正常、宽范围调节率的新型药理学和生物学起搏器,在动物模型中具有这些特征,并将其转化为人类,以靶向难治性人类 SSS。